Literature DB >> 24003905

Nager syndrome: confirmation of SF3B4 haploinsufficiency as the major cause.

F Petit1, F Escande, A S Jourdain, N Porchet, J Amiel, B Doray, M A Delrue, E Flori, C A Kim, S Marlin, S P Robertson, S Manouvrier-Hanu, M Holder-Espinasse.   

Abstract

Nager syndrome belongs to the group of acrofacial dysostosis, which are characterized by the association of craniofacial and limb malformations. Recently, exome sequencing studies identified the SF3B4 gene as the cause of this condition in most patients. SF3B4 encodes a highly conserved protein implicated in mRNA splicing and bone morphogenic protein (BMP) signaling. We performed SF3B4 sequencing in 14 families (18 patients) whose features were suggestive of Nager syndrome and found nine mutations predicted to result in loss-of-function. SF3B4 is the major gene responsible for autosomal dominant Nager syndrome. All mutations reported predict null alleles, therefore precluding genotype-phenotype correlations. Most mutation-negative patients were phenotypically indistinguishable from patients with mutations, suggesting genetic heterogeneity.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Nager syndrome; SF3B4; acro-facial dysostosis; spliceosome

Mesh:

Substances:

Year:  2013        PMID: 24003905     DOI: 10.1111/cge.12259

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  17 in total

1.  Holt-Oram syndrome: clinical and molecular description of 78 patients with TBX5 variants.

Authors:  Clémence Vanlerberghe; Anne-Sophie Jourdain; Jamal Ghoumid; Frédéric Frenois; Aurélie Mezel; Guy Vaksmann; Bruno Lenne; Bruno Delobel; Nicole Porchet; Valérie Cormier-Daire; Thomas Smol; Fabienne Escande; Sylvie Manouvrier-Hanu; Florence Petit
Journal:  Eur J Hum Genet       Date:  2018-12-14       Impact factor: 4.246

Review 2.  Rare syndromes of the head and face: mandibulofacial and acrofacial dysostoses.

Authors:  Karla Terrazas; Jill Dixon; Paul A Trainor; Michael J Dixon
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2017-02-10       Impact factor: 5.814

3.  A synonymous splicing mutation in the SF3B4 gene segregates in a family with highly variable Nager syndrome.

Authors:  Matteo Cassina; Cristina Cerqua; Silvia Rossi; Leonardo Salviati; Alessandro Martini; Maurizio Clementi; Eva Trevisson
Journal:  Eur J Hum Genet       Date:  2016-12-14       Impact factor: 4.246

4.  Synchronous Bilateral Breast Cancer in a Patient With Nager Syndrome.

Authors:  Ryan A Denu; Mark E Burkard
Journal:  Clin Breast Cancer       Date:  2017-01-05       Impact factor: 3.225

5.  Sf3b4-depleted Xenopus embryos: A model to study the pathogenesis of craniofacial defects in Nager syndrome.

Authors:  Arun Devotta; Hugo Juraver-Geslin; Jose Antonio Gonzalez; Chang-Soo Hong; Jean-Pierre Saint-Jeannet
Journal:  Dev Biol       Date:  2016-02-11       Impact factor: 3.582

6.  A 22-Week-Old Fetus with Nager Syndrome and Congenital Diaphragmatic Hernia due to a Novel SF3B4 Mutation.

Authors:  Marco Castori; Irene Bottillo; Daniela D'Angelantonio; Silvia Morlino; Carmelilia De Bernardo; Giovanna Scassellati Sforzolini; Evelina Silvestri; Paola Grammatico
Journal:  Mol Syndromol       Date:  2014-08-05

7.  Modeling human craniofacial disorders in Xenopus.

Authors:  Aditi Dubey; Jean-Pierre Saint-Jeannet
Journal:  Curr Pathobiol Rep       Date:  2017-01-24

Review 8.  RNA metabolism and links to inflammatory regulation and disease.

Authors:  Hui-Chi Lai; Uda Y Ho; Alexander James; Paul De Souza; Tara L Roberts
Journal:  Cell Mol Life Sci       Date:  2021-12-31       Impact factor: 9.261

Review 9.  Developmental processes regulate craniofacial variation in disease and evolution.

Authors:  Fjodor Merkuri; Jennifer L Fish
Journal:  Genesis       Date:  2018-10-01       Impact factor: 2.487

10.  Molecular mechanisms of hearing loss in Nager syndrome.

Authors:  Santosh Kumar Maharana; Jean-Pierre Saint-Jeannet
Journal:  Dev Biol       Date:  2021-04-14       Impact factor: 3.148

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.